NECTAR LIFESCIENCES
Back to Cashflow Statement
|
NECTAR LIFESCIENCES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹225 Cr | ₹134 Cr | ₹95 Cr | ₹21 Cr | ₹285 Cr |
What is the latest Cash Flow from Operating Activities ratio of NECTAR LIFESCIENCES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹225 Cr |
Mar2023 | ₹134 Cr |
Mar2022 | ₹95 Cr |
Mar2021 | ₹21 Cr |
Mar2020 | ₹285 Cr |
How is Cash Flow from Operating Activities of NECTAR LIFESCIENCES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹225 Cr | 68.11 | |
Mar2023 | ₹134 Cr | 40.68 | |
Mar2022 | ₹95 Cr | 344.38 | |
Mar2021 | ₹21 Cr | -92.50 | |
Mar2020 | ₹285 Cr | - |
Compare Cash Flow from Operating Activities of peers of NECTAR LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NECTAR LIFESCIENCES | ₹424.8 Cr | 2.2% | -19% | -33.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹414,533.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,215.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹120,428.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹116,410.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,253.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
NECTAR LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NECTAR LIFESCIENCES | 2.2% |
-19% |
-33.3% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses